Blue Sail Medical completes the acquisition of NVT
10 June 2020 – Blue Sail Medical Co., Ltd., a leading Chinese medical device company, listed at Shenzhen Stock Exchange, has entered into a share purchase agreement to acquire NVT AG on 20 September 2019. NVT develops, manufactures and markets medical devices for interventional cardiology and cardiac surgery for minimally invasive treatment of valvular heart disease. After receipt of the required regulatory permits and completion of the agreed carve-out the transaction was closed on 8 June 2020.
Walder Wyss AG acted as lead counsel to the private sellers. The team has been co-led by Urs P. Gnos (Partner, Corporate/M&A) and Samuel Lieberherr (Managing Associate, Corporate/M&A) and further included Markus Vischer (Partner, Corporate/M&A), Claudia Weber (Associate, Corporate/M&A, Janine Corti (Counsel, Tax), Simone Wetzstein (Managing Associate, Employment) and Lara Alec (Associate, Corporate/M&A).